Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
News headlines Recursion Pharmaceuticals reported mixed Q2 results, with revenue declining significantly and net loss improving. Despite progress in clinical trials and partnerships, analysts express ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results